Incyte (INCY) Change in Receivables (2010 - 2026)

Incyte (INCY) reported Change in Receivables of $27.0 million for Q1 2026, up 187.31% on a YoY basis from $9.4 million in Q1 2025, and down 78.97% quarter-over-quarter from $128.5 million in Q4 2025.

Incyte (INCY) Change in Receivables (2010 - 2026) Analysis & Trends

Incyte has reported Change in Receivables for 17 years, with the latest figure at $27.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Receivables rose 187.31% year-over-year to $27.0 million; the trailing twelve-month figure through Mar 2026 stood at $228.8 million (up 190.81% YoY), and the FY2025 full-year result was $170.8 million, up 53.04% from the prior year.
  • Change in Receivables for Q1 2026 stood at $27.0 million, down from $128.5 million in the prior quarter.
  • The five-year high for Change in Receivables was $128.5 million in Q4 2025, with the low at -$64.8 million in Q3 2022.
  • Historically, Change in Receivables has averaged $25.7 million across 5 years, with a median of $19.4 million in 2024.
  • The largest YoY upside for Change in Receivables was 412.37% in 2025 against a maximum downside of 1672.12% in 2025.
  • Incyte's Change in Receivables stood at $26.7 million in 2022, then jumped by 223.31% to $86.3 million in 2023, then gained by 12.05% to $96.7 million in 2024, then jumped by 32.89% to $128.5 million in 2025, then plunged by 78.97% to $27.0 million in 2026.
  • The last three Change in Receivables figures came in at $27.0 million (Q1 2026), $128.5 million (Q4 2025), and $53.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 22,529.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -39.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - -4.08 Mn
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 27.03 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 27.03 Mn
Mar 31, 2026 27.03 Mn
Dec 31, 2025 128.50 Mn
Dec 31, 2025 128.50 Mn
Sep 30, 2025 53.00 Mn
Sep 30, 2025 53.00 Mn
Jun 30, 2025 20.23 Mn
Jun 30, 2025 20.23 Mn
Mar 31, 2025 -30.96 Mn
Mar 31, 2025 -30.96 Mn
Dec 31, 2024 96.69 Mn
Dec 31, 2024 96.69 Mn
Sep 30, 2024 19.40 Mn
Sep 30, 2024 19.40 Mn
Jun 30, 2024 -6.48 Mn
Jun 30, 2024 -6.48 Mn
Mar 31, 2024 1.97 Mn
Mar 31, 2024 1.97 Mn
Dec 31, 2023 86.29 Mn
Dec 31, 2023 86.29 Mn